A phase I study of MEK inhibitor MEK162 (ARRY-438162) in patients with biliary tract cancer.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2562120582
